CHG-2024-0149
Formulation Change for Atezolimumab-R. Labeling Change for Atezolimumab-R — critical change. Impacts 4 markets and 1 variations.
Change Number
CHG-2024-0149
Type
Formulation Change
Product
Status
Blocked
Owner
Aisha Okonkwo
Initiated
2022-03-31
Description
Labeling Change for Atezolimumab-R — critical change
Impacted Markets (4)
CN — ChinaAU — AustraliaDE — GermanyPT — Portugal
Impacted Modules
3.2.P4.2.12.3.P
Linked Variations (0)
| Variation # | Type | Application | Status | Submitted | Approved |
|---|